E74-like factor 2 regulates valosin-containing protein expression

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 536-541

  Zhang, Binglin ^a   Tomita, Yasuhiko ^a   Qiu, Ying ^b   He, Juxiang ^a   Morii, Eiichi ^a   Noguchi, Shinzaburo ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TONGJI UNIVERSITY   (China)

Author keywords

Breast cancer; Cell survival; E74 like factor 2 new Ets related factor; Transcription factor; Valosin containing protein

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ELF2; TRANSCRIPTION FACTOR ETS; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; VCP GENE;

5' FLANKING REGION; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS;

EID: 33947643631     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.160     Document Type: Article

References (25)

1. Wang Q., Song C., and Li C.C. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J. Struct. Biol. 146 (2004) 44-57
2. Dai R.M., and Li C.C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 3 (2001) 740-744
3. Latterich M., Frohlich K.U., and Schekman R. Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 82 (1995) 885-893
4. Ye Y., Meyer H.H., and Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162 (2003) 71-84
5. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., Leonard G., Meyer H., van Heel M., and Freemont P.S. Structure of the AAA ATPase p97. Mol. Cell 6 (2000) 1473-1484
6. Dai R.M., Chen E., Longo D.L., Gorbea C.M., and Li C.C. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J. Biol. Chem. 273 (1998) 3562-3573
7. Asai T., Tomita Y., Nakatsuka S., Hoshida Y., Myoui A., Yoshikawa H., and Aozasa K. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn. J. Cancer Res. 93 (2002) 296-304
8. Yamamoto S., Tomita Y., Nakamori S., Hoshida Y., Nagano H., Dono K., Umeshita K., Sakon M., Monden M., and Aozasa K. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J. Clin. Oncol. 21 (2003) 447-452
9. Yamamoto S., Tomita Y., Hoshida Y., Takiguchi S., Fujiwara Y., Yasuda T., Yano M., Nakamori S., Sakon M., Monden M., and Aozasa K. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J. Clin. Oncol. 21 (2003) 2537-2544
10. Tsujimoto Y., Tomita Y., Hoshida Y., Kono T., Oka T., Yamamoto S., Nonomura N., Okuyama A., and Aozasa K. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin. Cancer Res. 10 (2004) 3007-3012
11. Yamamoto S., Tomita Y., Hoshida Y., Iizuka N., Kidogami S., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Yano M., Nakamori S., Sakon M., Monden M., and Aozasa K. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin. Cancer Res. 10 (2004) 5558-5565
12. Lu Q., Knoepfler P.S., Scheele J., Wright D.D., and Kamps M.P. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol. Cell. Biol. 15 (1995) 3786-3795
13. Qiu Y., Tomita Y., Zhang B., Nakamichi I., Morii E., and Aozasa K. Pre B cell leukemia transcription factor 1 (PBX1) regulates expression of Valosin-containing protein (VCP), A gene involved in cancer growth. Am. J. Pathol. 170 (2007) 152-159
14. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2 (2001) 827-837
15. Seth A., and Watson D.K. ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41 (2005) 2462-2478
16. Sementchenko V.I., and Watson D.K. Ets target genes: past, present and future. Oncogene 19 (2000) 6533-6548
17. Galang C.K., Muller W.J., Foos G., Oshima R.G., and Hauser C.A. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J. Biol. Chem. 279 (2004) 11281-11292
18. Oettgen P., Akbarali Y., Boltax J., Best J., Kunsch C., and Libermann T.A. Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1. Mol. Cell. Biol. 16 (1996) 5091-5106
19. Scott G.K., Chang C.H., Erny K.M., Xu F., Fredericks W.J., Rauscher III F.J., Thor A.D., and Benz C.C. Ets regulation of the erbB2 promoter. Oncogene 19 (2000) 6490-6502
20. Andreasen P.A., Kjoller L., Christensen L., and Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72 (1997) 1-22
21. Dube A., Thai S., Gaspar J., Rudders S., Libermann T.A., Iruela-Arispe L., and Oettgen P. Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ. Res. 88 (2001) 237-244
22. Gavrilov D., Kenzior O., Evans M., Calaluce R., and Folk W.R. Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers. Eur. J. Cancer 37 (2001) 1033-1040
23. Takai N., Miyazaki T., Nishida M., Shang S., Nasu K., and Miyakawa I. Clinical relevance of Elf-1 overexpression in endometrial carcinoma. Gynecol. Oncol. 89 (2003) 408-413
24. Cho J.Y., Akbarali Y., Zerbini L.F., Gu X., Boltax J., Wang Y., Oettgen P., Zhang D.E., and Libermann T.A. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene. J. Biol. Chem. 279 (2004) 19512-19522
25. Christensen R.A., Fujikawa K., Madore R., Oettgen P., and Varticovski L. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia. J. Cell. Biochem. 85 (2002) 505-515